Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants
收藏DataMed2026-07-12 收录
官方服务：
资源简介：
A study to investigate the safety and reactogenicity of MT-5625 independently in adults aged 18-35 years, toddlers ages 12-24 months, and infants aged 6-10 weeks
提供机构：
ClinicalTrials.gov
